JEFFREY J GOLDBERGER
Medical Practice at Little Elm Bnd, Skokie, IL

License number
Florida 111737
Issued Date
Dec 15, 2011
Effective Date
Sep 19, 2015
Expiration Date
Jan 31, 2018
Category
Health Care
Type
Medical Doctor
Address
Address 2
8912 Little Elm Bnd, Skokie, IL 60076
1295 NW 14Th St, Miami, FL 33136
Phone
(312) 714-4533

Professional information

Jeffrey Goldberger Photo 1

Electrophysiologic Testing Simulation For Medical Condition Determination

US Patent:
2011022, Sep 15, 2011
Filed:
Dec 20, 2010
Appl. No.:
12/972718
Inventors:
Jeffrey Goldberger - Skokie IL, US
Jason Ng - Evanston IL, US
International Classification:
G06G 7/60
US Classification:
703 11
Abstract:
A system simulates stimulation of scar tissue identified as hyper-enhanced areas in a medical image with variable luminance thresholds and categorizes partially-viable myocardium as distinct from non-viable scar tissue. A cardiac function analysis system includes a repository of imaging data representing a 3D volume comprising a patient heart. A model processor provides a model of the patient heart using the imaging data said model being for use in allocating electrical properties to model parameters determining electrical conductivity associated with image data classified as, (a) scar tissue, (b) impaired tissue and (c) normal heart tissue. The electrical properties allocated to scar tissue are different to electrical properties allocated to normal tissue. A stimulation processor simulates electrical stimulation of the patient heart using the model to identify risk of heart impairment.


Jeffrey Goldberger Photo 2

Devices And Methods For Suppression Of Sympathoexcitation

US Patent:
2011019, Aug 4, 2011
Filed:
Feb 1, 2011
Appl. No.:
13/018956
Inventors:
Jeffrey Goldberger - Skokie IL, US
International Classification:
A61N 1/362, A61N 1/39
US Classification:
607 5, 607 9, 607 14
Abstract:
The present invention relates to devices and methods for suppression of sympathoexcitation and/or sudden cardiac death. In particular the present invention provides devices and methods which prevent sympathoexcitation and/or sudden cardiac death through an elevated heart rate stimulus.


Jeffrey Goldberger Photo 3

Method For Preventing Thrombus Formation

US Patent:
2004001, Jan 22, 2004
Filed:
Feb 10, 2003
Appl. No.:
10/364143
Inventors:
Jeffrey Goldberger - Skokie IL, US
Assignee:
Gold-T Tech, Inc.
International Classification:
A61H001/00, A61N001/00
US Classification:
601/002000, 607/002000
Abstract:
The present invention provides devices and methods for preventing or significantly reducing the risk of thrombus formation. More specifically, the devices and methods of the present invention provide energy to blood flowing within a chamber or vessel to prevent or reduce blood stasis and thereby prevent or significantly reduce the risk of thrombus formation. The present invention is ideally suited for prevention or reduction of risk of blood clot formation in the atria in patients with atrial fibrillation, in blood vessels of patients at risk of clot formation, in areas adjacent to, or on, artificial heart valves or other artificial cardiovascular devices, and the like.


Jeffrey Goldberger Photo 4

Method For Preventing Thrombus Formation

US Patent:
8603086, Dec 10, 2013
Filed:
Apr 29, 2005
Appl. No.:
11/118742
Inventors:
Jeffrey J. Goldberger - Skokie IL, US
Assignee:
Gold-T Tech, Inc. - Skokie IL
International Classification:
A61M 31/00
US Classification:
606 41, 601 2, 601 3, 606 45, 606 47, 606 49, 607 96, 607 98, 607 99, 607100, 607101
Abstract:
The present invention provides devices and methods for preventing or significantly reducing the risk of thrombus formation. More specifically, the devices and methods of the present invention provide energy to blood flowing within a chamber or vessel to prevent or reduce blood stasis and thereby prevent or significantly reduce the risk of thrombus formation. The present invention is ideally suited for prevention or reduction of risk of blood clot formation in the atria in patients with atrial fibrillation, in blood vessels of patients at risk of clot formation, in areas adjacent to, or on, artificial heart valves or other artificial cardiovascular devices, and the like.